Barbara Ann Karmanos Cancer Institute/Wayne State University

Detroit, Michigan 48201

1 studies enrolling now · 4 studies all time

What they study most

Angioimmunoblastic T-cell Lymphoma, B-cell Acute Lymphoblastic Leukemia, Cancer, Chronic Lymphocytic Leukemia, Cutaneous T-Cell Lymphoma, Unspecified, Cutaneous T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Follicular T-Cell Lymphoma, Mycosis Fungoides, Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Not Classified, Peripheral T-cell Lymphoma

Studies at this site

• Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL) — Recruiting now
• Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma — Recruiting now
• Study of EC0489 for the Treatment of Refractory or Metastatic Tumors — Completed
• Study of the Vascular Disrupting Agent NPI-2358 in Patients With Advanced Solid Tumors or Lymphoma — Completed